A Randomized, Double-blind, Two Period, Cross Over Glucose Clamp Study to Test for Bioeqivalence Between Two Long Acting Insulin Analogs-Wockhardt's Glaritus (Insulin Glargine) and Lantus (Insulin Glargine) in Subjects With Type 1 Diabetes

Trial Profile

A Randomized, Double-blind, Two Period, Cross Over Glucose Clamp Study to Test for Bioeqivalence Between Two Long Acting Insulin Analogs-Wockhardt's Glaritus (Insulin Glargine) and Lantus (Insulin Glargine) in Subjects With Type 1 Diabetes

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Jan 2013

At a glance

  • Drugs Insulin glargine (Primary)
  • Indications Type 1 diabetes mellitus
  • Focus Pharmacodynamics; Pharmacokinetics
  • Sponsors Wockhardt
  • Most Recent Events

    • 21 Nov 2011 Planned end date changed from 1 Jan 2012 to 1 Jun 2012 as reported by ClinicalTrials.gov.
    • 21 Nov 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 24 May 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top